Millennium Management
LBRX

Millennium Management’s LB Pharmaceuticals LBRX Stock Holding History

Millennium Management’s Portfolio LBRX Stock Details LBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.38M Buy
+136,966
New +$3.16M ﹤0.01% 3360
2025
Q4 		– Sell
-538,169
Closed -$8.5M – 6641
2025
Q3 		$8.5M Buy
+538,169
New +$8.54M ﹤0.01% 2559

Other funds holding LBRX

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
SSC
Spruce Street Capital New York $416M AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Millennium Management's LBRX Position: Q1 2026 in Review

Millennium Management opened a new position in LB Pharmaceuticals (LBRX) in Q1 2026: 136,966 shares worth $3.38M. The stake represents ﹤0.01% of the portfolio and ranks #3360 among its holdings. This is a return to the name: Millennium Management previously reported a position in LBRX as recently as Q3 2025.

Millennium Management first reported a position in LBRX in Q3 2025 and has held it in 2 quarters since. The position peaked at $8.5M in Q3 2025. 77 funds tracked by Wall St. Rank hold LBRX as of Q1 2026.

  • Millennium Management held 136,966 shares of LB Pharmaceuticals worth $3.38M as of Q1 2026.
  • LB Pharmaceuticals was a new Millennium Management position in Q1 2026.
  • LB Pharmaceuticals made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #3360 holding.
  • Millennium Management first reported a position in LB Pharmaceuticals in Q3 2025 and has held it in 2 quarters since.
  • Millennium Management's LB Pharmaceuticals position peaked at $8.5M in Q3 2025.
  • 77 funds tracked by Wall St. Rank held LB Pharmaceuticals as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.